Información del producto
- 2-Naphthalenecarboxylic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 10,11-dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine (1:2)
- 2-Naphthoic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine
- 2-Naphthoic acid, 4,4′-methylenebis[3-hydroxy-, compd. with 5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine (1:2)
- 4,4'-methanediylbis(3-hydroxynaphthalene-2-carboxylic acid) - 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine (1:2)
- 5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)propyl]-10,11-dihydro-, 4,4′-methylenebis[3-hydroxy-2-naphthoate] (2:1)
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-, 4,4′-methylenebis[3-hydroxy-2-naphthalenecarboxylate] (2:1)
- Imipramine Pamoate
Imipramine pamoate is a kinase inhibitor that has been shown to induce apoptosis in human cancer cells. It is an analog of amphetamine and has potent anticancer activity. Imipramine pamoate works by inhibiting the activity of several kinases, including protein kinase C and mitogen-activated protein kinase (MAPK), which are involved in cell growth and survival. This drug has been found to be effective against a variety of tumors, including breast, lung, and colon cancers. Imipramine pamoate is excreted in urine and can be used as a biomarker for cancer diagnosis or monitoring.
Propiedades químicas
Consulta técnica sobre: 3D-KAA07524 Imipramine pamoate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.